|
| Human LILRB1/CD85j/ILT2 Protein (LTP10899) |
|
| LTP10899 |
|
| 100ug |
|
|
$305 In stock |
| LILRB1, also known as CD85j and ILT2, is a 110 kDa transmembrane glycoprotein in the LILR immunoregulatory protein family. Mature human LILRB1 consists of a 438 amino acid (aa) extracellular domain (ECD) with 4 tandem Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 4 inhibitory ITIM motifs.LILRB1 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. Receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response. |
| Recombinant Human LILRB1/CD85j/ILT2 Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal. It contains Gly24-His458. |
|
| LILRB1/CD85j/ILT2 |
|
| Human |
|
| Q8NHL6-1 |
|
| Gly24-His458 |
|
| The protein has a predicted MW of 50 kDa. Due to glycosylation, the protein migrates to 72-78 kDa based on the Tris-Bis PAGE result. |
|
| Immobilized Human LILRB1, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-LILRB1 Antibody, hFc Tag with the EC50 of 10.3ng/ml determined by ELISA. See testing image for detail. |
|
| C-His-Avi |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
